Rituximab maintenance therapy of follicular lymphoma in clinical practice

Abstract Standard of care for patients with symptomatic, advanced‐stage follicular lymphoma (FL) is rituximab‐containing chemoimmunotherapy followed by rituximab maintenance. This prospective, multicenter, noninterventional study analyzed how efficacy and safety data from randomized controlled trial...

Full description

Bibliographic Details

Published in:	Cancer Medicine
Main Authors:	Ulrich Dührsen, Stefanie Broszeit‐Luft, Annette Dieing, Andreas Lück, Piotr Porowski, Marcel Reiser, Ulrike Schwinger, Sandra Klawitter, Katja Krumm, Kathleen Jentsch‐Ullrich
Format:	Article
Language:	English
Published:	Wiley 2018-07-01
Subjects:	chemoimmunotherapy follicular lymphoma observational study rituximab
Online Access:	https://doi.org/10.1002/cam4.1549